…Manifest Huntington’s Disease. No. of study participants and sites: This open-label study aims to recruit participants from 2 sites in France. For further information see the clinical trial registration…. […]
…drug on the clinical course of HD. Dosing is also being paused on the open label extension study, GEN-EXTEND. This decision is the outcome of a pre-planned review of the… […]
…drug on the clinical course of HD. Dosing is also being paused on the open label extension study, GEN-EXTEND. This decision is the outcome of a pre-planned review of the… […]